+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Liver Cancer Diagnostics Market by Disease Stage (Advanced Stage, Early Stage), End User (Ambulatory Care, Diagnostic Centers, Hospitals), Test Type, Technology - Global Forecast 2025-2030- Product Image
Liver Cancer Diagnostics Market by Disease Stage (Advanced Stage, Early Stage), End User (Ambulatory Care, Diagnostic Centers, Hospitals), Test Type, Technology - Global Forecast 2025-2030- Product Image
Sale

Liver Cancer Diagnostics Market by Disease Stage (Advanced Stage, Early Stage), End User (Ambulatory Care, Diagnostic Centers, Hospitals), Test Type, Technology - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 180 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5716289
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The liver cancer diagnostics market is evolving to deliver greater clinical precision and operational efficiency, driven by advances in technology and the growing demands of health systems worldwide. As the need for early and accurate detection intensifies, senior decision-makers face an increasingly complex landscape of technological, regulatory, and strategic considerations.

Market Snapshot: Liver Cancer Diagnostics Market Growth and Prospects

The Liver Cancer Diagnostics Market grew from USD 10.05 billion in 2024 to USD 10.73 billion in 2025, with projections to reach USD 14.75 billion by 2030 at a CAGR of 6.59%. This upward trend is supported by the rapid adoption of advanced diagnostic assays, integration of cutting-edge imaging modalities, and increasing prevalence of liver cancer worldwide. The market’s momentum is sustained by investments in molecular diagnostics, collaborative research models, and the translation of real-world evidence into clinical practice.

Scope & Segmentation

This report delivers a comprehensive analysis across the breadth of liver cancer diagnostics, highlighting segmentation by disease stage, user groups, diagnostic methods, technologies, and key regional markets.

  • Disease Stage: Early stage, Advanced stage
  • End User: Ambulatory care, Diagnostic centers, Hospitals, Research laboratories
  • Test Type: Biomarkers (Genetic markers, Protein markers), Biopsy, Genetic testing, Imaging modalities
  • Technology: CT, MRI, PET, Ultrasound
  • Regions: Americas (notably United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, Russia, Saudi Arabia, Nigeria), Asia-Pacific (such as China, India, Japan, Australia, South Korea, Vietnam)
  • Leading Companies: F. Hoffmann-La Roche Ltd., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Thermo Fisher Scientific Inc., bioMérieux SA, Hologic Inc., QIAGEN N.V., Sysmex Corporation, Illumina Inc.

Key Takeaways for Senior Decision-Makers

  • Integration of genomics, imaging, and digital technologies is reshaping clinical algorithms, enabling earlier and more personalized liver cancer detection strategies.
  • Shifting patient demographics and advances in high-resolution imaging are expanding the applicability of multi-modal diagnostic approaches across diverse care settings.
  • Collaborative research partnerships between healthcare providers, industry leaders, and academic institutions streamline the movement of novel diagnostics from development to clinical adoption.
  • Customization of testing workflows and technology platforms to specific end-users supports operational efficiency, from point-of-care sites to central laboratories.
  • Regional variations in health infrastructure and regulatory ecosystems inform the pace and nature of market penetration, underscoring the value of tailored strategies for deployment and investment.
  • Modular and scalable diagnostic solutions address evolving clinical guidelines and support long-term flexibility amid fast-changing policy environments.

Tariff Impact on Supply Chain and Strategic Planning

Recent U.S. trade tariffs on imported diagnostic instruments and reagents have raised input costs and complicated procurement planning for stakeholders throughout the value chain. Many laboratories and health systems are responding by adjusting sourcing arrangements, emphasizing local manufacturing partnerships, and reviewing product portfolios to enhance supply chain resilience. This environment makes agile supply strategies and modular system designs essential for minimizing disruptions while maintaining performance standards.

Methodology & Data Sources

The report is grounded in a robust research framework combining secondary market data with in-depth interviews from leading oncology experts, laboratory directors, and regulatory officials. Trend extrapolation, data triangulation, and external peer review were applied to ensure analytical rigor and credible, decision-ready insights.

Why This Report Matters

  • Gives stakeholders a detailed roadmap to navigate market shifts, regulatory trends, and technology transitions in liver cancer diagnostics.
  • Supports data-driven planning and investment prioritization by offering clear insights into segment-specific opportunities across regions and technologies.

Conclusion

Continuous advancements in liver cancer diagnostics underscore the importance of adaptable strategies and robust stakeholder collaboration. Senior leaders who leverage these insights will be positioned to enhance patient outcomes and secure long-term growth in this dynamic market.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of circulating tumor DNA assays for early detection and monitoring
5.2. Emergence of AI-enabled imaging platforms for enhanced lesion characterization in HCC screening
5.3. Adoption of multi-omic liquid biopsy panels combining ctDNA, proteomics and methylation markers
5.4. Expansion of non-invasive breath diagnostic tests detecting volatile organic compounds in liver cancer
5.5. Incorporation of point-of-care ultrasound elastography into community-based liver cancer surveillance programs
5.6. Implementation of predictive analytics integrating radiomics and genomics for personalized surveillance protocols
5.7. Development of glycoprotein biomarker panels including AFP-L3, DCP and novel lectin-based assays
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Liver Cancer Diagnostics Market, by Disease Stage
8.1. Introduction
8.2. Advanced Stage
8.3. Early Stage
9. Liver Cancer Diagnostics Market, by End User
9.1. Introduction
9.2. Ambulatory Care
9.3. Diagnostic Centers
9.4. Hospitals
9.5. Research Laboratories
10. Liver Cancer Diagnostics Market, by Test Type
10.1. Introduction
10.2. Biomarkers
10.2.1. Genetic Markers
10.2.1.1. ctDNA Tests
10.2.1.2. MicroRNA Tests
10.2.2. Protein Markers
10.2.2.1. AFP Tests
10.2.2.2. DCP Tests
10.3. Biopsy
10.3.1. Core Needle Biopsy
10.3.2. Fine Needle Aspiration
10.4. Genetic Testing
10.4.1. Next-Generation Sequencing
10.4.2. PCR Analysis
10.5. Imaging
10.5.1. CT
10.5.2. MRI
10.5.3. PET
10.5.4. Ultrasound
11. Liver Cancer Diagnostics Market, by Technology
11.1. Introduction
11.2. CT
11.3. MRI
11.4. PET
11.5. Ultrasound
12. Americas Liver Cancer Diagnostics Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Liver Cancer Diagnostics Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Liver Cancer Diagnostics Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. F. Hoffmann-La Roche Ltd.
15.3.2. Abbott Laboratories
15.3.3. Danaher Corporation
15.3.4. Siemens Healthineers AG
15.3.5. Thermo Fisher Scientific Inc.
15.3.6. bioMérieux SA
15.3.7. Hologic, Inc.
15.3.8. QIAGEN N.V.
15.3.9. Sysmex Corporation
15.3.10. Illumina, Inc.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. LIVER CANCER DIAGNOSTICS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL LIVER CANCER DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY DISEASE STAGE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY DISEASE STAGE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 8. GLOBAL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 12. GLOBAL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS LIVER CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS LIVER CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES LIVER CANCER DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES LIVER CANCER DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC LIVER CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC LIVER CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. LIVER CANCER DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. LIVER CANCER DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. LIVER CANCER DIAGNOSTICS MARKET: RESEARCHAI
FIGURE 24. LIVER CANCER DIAGNOSTICS MARKET: RESEARCHSTATISTICS
FIGURE 25. LIVER CANCER DIAGNOSTICS MARKET: RESEARCHCONTACTS
FIGURE 26. LIVER CANCER DIAGNOSTICS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. LIVER CANCER DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL LIVER CANCER DIAGNOSTICS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL LIVER CANCER DIAGNOSTICS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY DISEASE STAGE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY DISEASE STAGE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY ADVANCED STAGE, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY ADVANCED STAGE, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY EARLY STAGE, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY EARLY STAGE, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC MARKERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC MARKERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY CTDNA TESTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY CTDNA TESTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY MICRORNA TESTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY MICRORNA TESTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC MARKERS, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC MARKERS, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY PROTEIN MARKERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY PROTEIN MARKERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY AFP TESTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY AFP TESTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY DCP TESTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY DCP TESTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY PROTEIN MARKERS, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY PROTEIN MARKERS, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKERS, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKERS, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOPSY, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOPSY, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY CORE NEEDLE BIOPSY, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY CORE NEEDLE BIOPSY, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY FINE NEEDLE ASPIRATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY FINE NEEDLE ASPIRATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOPSY, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOPSY, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY PCR ANALYSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY PCR ANALYSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY CT, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY CT, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY MRI, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY MRI, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY PET, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY PET, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY ULTRASOUND, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY CT, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY CT, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY MRI, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY MRI, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY PET, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY PET, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY ULTRASOUND, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS LIVER CANCER DIAGNOSTICS MARKET SIZE, BY DISEASE STAGE, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS LIVER CANCER DIAGNOSTICS MARKET SIZE, BY DISEASE STAGE, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS LIVER CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS LIVER CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKERS, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKERS, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS LIVER CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC MARKERS, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS LIVER CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC MARKERS, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS LIVER CANCER DIAGNOSTICS MARKET SIZE, BY PROTEIN MARKERS, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS LIVER CANCER DIAGNOSTICS MARKET SIZE, BY PROTEIN MARKERS, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOPSY, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOPSY, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS LIVER CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS LIVER CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS LIVER CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS LIVER CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS LIVER CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS LIVER CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES LIVER CANCER DIAGNOSTICS MARKET SIZE, BY DISEASE STAGE, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES LIVER CANCER DIAGNOSTICS MARKET SIZE, BY DISEASE STAGE, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES LIVER CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES LIVER CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKERS, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKERS, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES LIVER CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC MARKERS, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES LIVER CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC MARKERS, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES LIVER CANCER DIAGNOSTICS MARKET SIZE, BY PROTEIN MARKERS, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES LIVER CANCER DIAGNOSTICS MARKET SIZE, BY PROTEIN MARKERS, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOPSY, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOPSY, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES LIVER CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES LIVER CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES LIVER CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES LIVER CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES LIVER CANCER DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES LIVER CANCER DIAGNOSTICS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 129. CANADA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY DISEASE STAGE, 2018-2024 (USD MILLION)
TABLE 130. CANADA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY DISEASE STAGE, 2025-2030 (USD MILLION)
TABLE 131. CANADA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 132. CANADA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 133. CANADA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 134. CANADA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 135. CANADA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKERS, 2018-2024 (USD MILLION)
TABLE 136. CANADA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKERS, 2025-2030 (USD MILLION)
TABLE 137. CANADA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC MARKERS, 2018-2024 (USD MILLION)
TABLE 138. CANADA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC MARKERS, 2025-2030 (USD MILLION)
TABLE 139. CANADA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY PROTEIN MARKERS, 2018-2024 (USD MILLION)
TABLE 140. CANADA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY PROTEIN MARKERS, 2025-2030 (USD MILLION)
TABLE 141. CANADA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOPSY, 2018-2024 (USD MILLION)
TABLE 142. CANADA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOPSY, 2025-2030 (USD MILLION)
TABLE 143. CANADA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2018-2024 (USD MILLION)
TABLE 144. CANADA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2025-2030 (USD MILLION)
TABLE 145. CANADA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 146. CANADA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 147. CANADA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 148. CANADA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 149. MEXICO LIVER CANCER DIAGNOSTICS MARKET SIZE, BY DISEASE STAGE, 2018-2024 (USD MILLION)
TABLE 150. MEXICO LIVER CANCER DIAGNOSTICS MARKET SIZE, BY DISEASE STAGE, 2025-2030 (USD MILLION)
TABLE 151. MEXICO LIVER CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 152. MEXICO LIVER CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 153. MEXICO LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 154. MEXICO LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 155. MEXICO LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKERS, 2018-2024 (USD MILLION)
TABLE 156. MEXICO LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKERS, 2025-2030 (USD MILLION)
TABLE 157. MEXICO LIVER CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC MARKERS, 2018-2024 (USD MILLION)
TABLE 158. MEXICO LIVER CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC MARKERS, 2025-2030 (USD MILLION)
TABLE 159. MEXICO LIVER CANCER DIAGNOSTICS MARKET SIZE, BY PROTEIN MARKERS, 2018-2024 (USD MILLION)
TABLE 160. MEXICO LIVER CANCER DIAGNOSTICS MARKET SIZE, BY PROTEIN MARKERS, 2025-2030 (USD MILLION)
TABLE 161. MEXICO LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOPSY, 2018-2024 (USD MILLION)
TABLE 162. MEXICO LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOPSY, 2025-2030 (USD MILLION)
TABLE 163. MEXICO LIVER CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2018-2024 (USD MILLION)
TABLE 164. MEXICO LIVER CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2025-2030 (USD MILLION)
TABLE 165. MEXICO LIVER CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 166. MEXICO LIVER CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 167. MEXICO LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 168. MEXICO LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 169. BRAZIL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY DISEASE STAGE, 2018-2024 (USD MILLION)
TABLE 170. BRAZIL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY DISEASE STAGE, 2025-2030 (USD MILLION)
TABLE 171. BRAZIL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 172. BRAZIL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 173. BRAZIL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 174. BRAZIL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 175. BRAZIL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKERS, 2018-2024 (USD MILLION)
TABLE 176. BRAZIL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKERS, 2025-2030 (USD MILLION)
TABLE 177. BRAZIL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC MARKERS, 2018-2024 (USD MILLION)
TABLE 178. BRAZIL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC MARKERS, 2025-2030 (USD MILLION)
TABLE 179. BRAZIL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY PROTEIN MARKERS, 2018-2024 (USD MILLION)
TABLE 180. BRAZIL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY PROTEIN MARKERS, 2025-2030 (USD MILLION)
TABLE 181. BRAZIL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOPSY, 2018-2024 (USD MILLION)
TABLE 182. BRAZIL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOPSY, 2025-2030 (USD MILLION)
TABLE 183. BRAZIL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2018-2024 (USD MILLION)
TABLE 184. BRAZIL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2025-2030 (USD MILLION)
TABLE 185. BRAZIL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 186. BRAZIL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 187. BRAZIL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 188. BRAZIL LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 189. ARGENTINA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY DISEASE STAGE, 2018-2024 (USD MILLION)
TABLE 190. ARGENTINA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY DISEASE STAGE, 2025-2030 (USD MILLION)
TABLE 191. ARGENTINA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 192. ARGENTINA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 193. ARGENTINA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 194. ARGENTINA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 195. ARGENTINA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKERS, 2018-2024 (USD MILLION)
TABLE 196. ARGENTINA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKERS, 2025-2030 (USD MILLION)
TABLE 197. ARGENTINA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC MARKERS, 2018-2024 (USD MILLION)
TABLE 198. ARGENTINA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC MARKERS, 2025-2030 (USD MILLION)
TABLE 199. ARGENTINA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY PROTEIN MARKERS, 2018-2024 (USD MILLION)
TABLE 200. ARGENTINA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY PROTEIN MARKERS, 2025-2030 (USD MILLION)
TABLE 201. ARGENTINA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOPSY, 2018-2024 (USD MILLION)
TABLE 202. ARGENTINA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOPSY, 2025-2030 (USD MILLION)
TABLE 203. ARGENTINA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2018-2024 (USD MILLION)
TABLE 204. ARGENTINA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2025-2030 (USD MILLION)
TABLE 205. ARGENTINA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 206. ARGENTINA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 207. ARGENTINA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 208. ARGENTINA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY DISEASE STAGE, 2018-2024 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY DISEASE STAGE, 2025-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKERS, 2018-2024 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKERS, 2025-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC MARKERS, 2018-2024 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC MARKERS, 2025-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY PROTEIN MARKERS, 2018-2024 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY PROTEIN MARKERS, 2025-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOPSY, 2018-2024 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOPSY, 2025-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2018-2024 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2025-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 230. EUROPE, MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM LIVER CANCER DIAGNOSTICS MARKET SIZE, BY DISEASE STAGE, 2018-2024 (USD MILLION)
TABLE 232. UNITED KINGDOM LIVER CANCER DIAGNOSTICS MARKET SIZE, BY DISEASE STAGE, 2025-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM LIVER CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 234. UNITED KINGDOM LIVER CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 236. UNITED KINGDOM LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKERS, 2018-2024 (USD MILLION)
TABLE 238. UNITED KINGDOM LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKERS, 2025-2030 (USD MILLION)
TABLE 239. UNITED KINGDOM LIVER CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC MARKERS, 2018-2024 (USD MILLION)
TABLE 240. UNITED KINGDOM LIVER CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC MARKERS, 2025-2030 (USD MILLION)
TABLE 241. UNITED KINGDOM LIVER CANCER DIAGNOSTICS MARKET SIZE, BY PROTEIN MARKERS, 2018-2024 (USD MILLION)
TABLE 242. UNITED KINGDOM LIVER CANCER DIAGNOSTICS MARKET SIZE, BY PROTEIN MARKERS, 2025-2030 (USD MILLION)
TABLE 243. UNITED KINGDOM LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOPSY, 2018-2024 (USD MILLION)
TABLE 244. UNITED KINGDOM LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOPSY, 2025-2030 (USD MILLION)
TABLE 245. UNITED KINGDOM LIVER CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2018-2024 (USD MILLION)
TABLE 246. UNITED KINGDOM LIVER CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2025-2030 (USD MILLION)
TABLE 247. UNITED KINGDOM LIVER CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 248. UNITED KINGDOM LIVER CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 249. UNITED KINGDOM LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 250. UNITED KINGDOM LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 251. GERMANY LIVER CANCER DIAGNOSTICS MARKET SIZE, BY DISEASE STAGE, 2018-2024 (USD MILLION)
TABLE 252. GERMANY LIVER CANCER DIAGNOSTICS MARKET SIZE, BY DISEASE STAGE, 2025-2030 (USD MILLION)
TABLE 253. GERMANY LIVER CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 254. GERMANY LIVER CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 255. GERMANY LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 256. GERMANY LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 257. GERMANY LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKERS, 2018-2024 (USD MILLION)
TABLE 258. GERMANY LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKERS, 2025-2030 (USD MILLION)
TABLE 259. GERMANY LIVER CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC MARKERS, 2018-2024 (USD MILLION)
TABLE 260. GERMANY LIVER CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC MARKERS, 2025-2030 (USD MILLION)
TABLE 261. GERMANY LIVER CANCER DIAGNOSTICS MARKET SIZE, BY PROTEIN MARKERS, 2018-2024 (USD MILLION)
TABLE 262. GERMANY LIVER CANCER DIAGNOSTICS MARKET SIZE, BY PROTEIN MARKERS, 2025-2030 (USD MILLION)
TABLE 263. GERMANY LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOPSY, 2018-2024 (USD MILLION)
TABLE 264. GERMANY LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOPSY, 2025-2030 (USD MILLION)
TABLE 265. GERMANY LIVER CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2018-2024 (USD MILLION)
TABLE 266. GERMANY LIVER CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2025-2030 (USD MILLION)
TABLE 267. GERMANY LIVER CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 268. GERMANY LIVER CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 269. GERMANY LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 270. GERMANY LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 271. FRANCE LIVER CANCER DIAGNOSTICS MARKET SIZE, BY DISEASE STAGE, 2018-2024 (USD MILLION)
TABLE 272. FRANCE LIVER CANCER DIAGNOSTICS MARKET SIZE, BY DISEASE STAGE, 2025-2030 (USD MILLION)
TABLE 273. FRANCE LIVER CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 274. FRANCE LIVER CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 275. FRANCE LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 276. FRANCE LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 277. FRANCE LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKERS, 2018-2024 (USD MILLION)
TABLE 278. FRANCE LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKERS, 2025-2030 (USD MILLION)
TABLE 279. FRANCE LIVER CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC MARKERS, 2018-2024 (USD MILLION)
TABLE 280. FRANCE LIVER CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC MARKERS, 2025-2030 (USD MILLION)
TABLE 281. FRANCE LIVER CANCER DIAGNOSTICS MARKET SIZE, BY PROTEIN MARKERS, 2018-2024 (USD MILLION)
TABLE 282. FRANCE LIVER CANCER DIAGNOSTICS MARKET SIZE, BY PROTEIN MARKERS, 2025-2030 (USD MILLION)
TABLE 283. FRANCE LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOPSY, 2018-2024 (USD MILLION)
TABLE 284. FRANCE LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOPSY, 2025-2030 (USD MILLION)
TABLE 285. FRANCE LIVER CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2018-2024 (USD MILLION)
TABLE 286. FRANCE LIVER CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2025-2030 (USD MILLION)
TABLE 287. FRANCE LIVER CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 288. FRANCE LIVER CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 289. FRANCE LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 290. FRANCE LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 291. RUSSIA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY DISEASE STAGE, 2018-2024 (USD MILLION)
TABLE 292. RUSSIA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY DISEASE STAGE, 2025-2030 (USD MILLION)
TABLE 293. RUSSIA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 294. RUSSIA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 295. RUSSIA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 296. RUSSIA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 297. RUSSIA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKERS, 2018-2024 (USD MILLION)
TABLE 298. RUSSIA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKERS, 2025-2030 (USD MILLION)
TABLE 299. RUSSIA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC MARKERS, 2018-2024 (USD MILLION)
TABLE 300. RUSSIA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC MARKERS, 2025-2030 (USD MILLION)
TABLE 301. RUSSIA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY PROTEIN MARKERS, 2018-2024 (USD MILLION)
TABLE 302. RUSSIA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY PROTEIN MARKERS, 2025-2030 (USD MILLION)
TABLE 303. RUSSIA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOPSY, 2018-2024 (USD MILLION)
TABLE 304. RUSSIA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOPSY, 2025-2030 (USD MILLION)
TABLE 305. RUSSIA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2018-2024 (USD MILLION)
TABLE 306. RUSSIA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2025-2030 (USD MILLION)
TABLE 307. RUSSIA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 308. RUSSIA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 309. RUSSIA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 310. RUSSIA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 311. ITALY LIVER CANCER DIAGNOSTICS MARKET SIZE, BY DISEASE STAGE, 2018-2024 (USD MILLION)
TABLE 312. ITALY LIVER CANCER DIAGNOSTICS MARKET SIZE, BY DISEASE STAGE, 2025-2030 (USD MILLION)
TABLE 313. ITALY LIVER CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 314. ITALY LIVER CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 315. ITALY LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 316. ITALY LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 317. ITALY LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKERS, 2018-2024 (USD MILLION)
TABLE 318. ITALY LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKERS, 2025-2030 (USD MILLION)
TABLE 319. ITALY LIVER CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC MARKERS, 2018-2024 (USD MILLION)
TABLE 320. ITALY LIVER CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC MARKERS, 2025-2030 (USD MILLION)
TABLE 321. ITALY LIVER CANCER DIAGNOSTICS MARKET SIZE, BY PROTEIN MARKERS, 2018-2024 (USD MILLION)
TABLE 322. ITALY LIVER CANCER DIAGNOSTICS MARKET SIZE, BY PROTEIN MARKERS, 2025-2030 (USD MILLION)
TABLE 323. ITALY LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOPSY, 2018-2024 (USD MILLION)
TABLE 324. ITALY LIVER CANCER DIAGNOSTICS MARKET SIZE, BY BIOPSY, 2025-2030 (USD MILLION)
TABLE 325. ITALY LIVER CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2018-2024 (USD MILLION)
TABLE 326. ITALY LIVER CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2025-2030 (USD MILLION)
TABLE 327. ITALY LIVER CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 328. ITALY LIVER CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 329. ITALY LIVER CANCER DIAGNOSTICS MARKET SI

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Liver Cancer Diagnostics market report include:
  • F. Hoffmann-La Roche Ltd.
  • Abbott Laboratories
  • Danaher Corporation
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
  • bioMérieux SA
  • Hologic, Inc.
  • QIAGEN N.V.
  • Sysmex Corporation
  • Illumina, Inc.

Table Information

Report AttributeDetails
No. of Pages180
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 10.73 Billion
Forecasted Market Value ( USD ) by 2030 $ 14.75 Billion
Compound Annual Growth Rate6.5%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Liver Cancer Diagnostics Market Size, Share & Trends Analysis Report by Test Type (Laboratory Tests, Imaging, Endoscopy, Biopsy), End-use (Hospitals & Diagnostic Laboratories, Pharmaceutical & CRO Laboratories), and Region with Growth Forecasts, 2025-2030 - Product Image

Liver Cancer Diagnostics Market Size, Share & Trends Analysis Report by Test Type (Laboratory Tests, Imaging, Endoscopy, Biopsy), End-use (Hospitals & Diagnostic Laboratories, Pharmaceutical & CRO Laboratories), and Region with Growth Forecasts, 2025-2030

  • Report
  • 150 Pages
  • Global
From
Liver Cancer Diagnostics Market Report 2025 - Product Image

Liver Cancer Diagnostics Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Liver Cancer Diagnostics - Global Strategic Business Report - Product Image

Liver Cancer Diagnostics - Global Strategic Business Report

  • Report
  • 275 Pages
  • Global
From
Liver Cancer Diagnostic Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Liver Cancer Diagnostic Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Cancer Diagnostics Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033 - Product Image

Cancer Diagnostics Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033

  • Report
  • 140 Pages
  • Global
From

About the Liver Cancer Diagnostics Market

The Liver Cancer Diagnostics market is a subset of the larger Diagnostics industry. It is focused on the development and commercialization of tests and technologies used to detect and diagnose liver cancer. These tests can include imaging techniques such as ultrasound, computed tomography (CT) scans, and magnetic resonance imaging (MRI). Additionally, blood tests, biopsies, and other laboratory tests may be used to diagnose liver cancer. The Liver Cancer Diagnostics market is highly competitive, with a range of companies offering products and services. These include Roche Diagnostics, Abbott Laboratories, Siemens Healthineers, Becton Dickinson, and Hologic. Other companies in the market include Agilent Technologies, Bio-Rad Laboratories, and Cepheid. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.